Age- and sex-dependence of dopamine release and capacity for recovery identified in the dorsal striatum of C57/Bl6J mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Arvidsson, Emma ^a   Viereckel, Thomas ^a   Mikulovic, Sanja ^a   Wallén Mackenzie, Åsa ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

AGE; AMPEROMETRY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; DORSAL STRIATUM; ELECTROCHEMICAL ANALYSIS; FEMALE; IN VIVO STUDY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; SEX DIFFERENCE; SUBSTANTIA NIGRA PARS COMPACTA; AGING; ANIMAL; C57BL MOUSE; CONVALESCENCE; CYTOLOGY; DOPAMINERGIC NERVE CELL; KINETICS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY;

AGE FACTORS; AGING; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; FEMALE; KINETICS; MALE; MICE; MICE, INBRED C57BL; RECOVERY OF FUNCTION; SEX FACTORS;

EID: 84903385558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099592     Document Type: Article

References (31)

1. Andén NE, Carlsson A, Dahlström A, Fuxe K, Hillarp NÅ, et al. (1964) Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sciences 3: 523-530.
2. Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, et al. (2008) Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease. Movement Disorders 23: S548-S559.
3. Yin HH, Knowlton BJ (2006) The role of the basal ganglia in habit formation. Nature Reviews Neuroscience 7: 464-476. (Pubitemid 44012286)
4. Baldan Ramsey LC, Xu M, Wood N, Pittenger C (2011) Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 180: 222-228.
5. Wightman RM, Robinson DL (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. J Neurochem 82: 721-735.
6. Rios M, Habecker B, Sasaoka T, Eisenhofer G, Tian H, et al. (1999) Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 19: 3519-3526. (Pubitemid 29203131)
7. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, et al. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15: 1714-1723.
8. Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, et al. (1995) Differential expression of two vesicular monoamine transporters. J Neurosci 15: 6179-6188.
9. Elsworth JD, Roth RH (1997) Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease. Experimental Neurology 144: 4-9. (Pubitemid 27149594)
10. Riccardi P, Li R, Ansari MS, Zald D, Park S, et al. (2006) Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31: 1016-1026.
11. Walker QD, Rooney MB, Wightman RM, Kuhn CM (1999) Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience 95: 1061-1070. (Pubitemid 30006894)
12. Ji J, McDermott JL, Dluzen DE (2007) Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. J Neuroendocrinol 19: 725-731. (Pubitemid 47386546)
13. Stamford JA (1989) Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. Journal of neurochemistry 52: 1582-1589.
14. Nakano M, Oenzil F, Mizuno T, Gotoh S (1995) Age-related changes in the lipofuscin accumulation of brain and heart. Gerontology 41 Suppl 2: 69-79. (Pubitemid 26019907)
15. Kumar V, Kim K, Joseph C, Kourrich S, Yoo SH, et al. (2013) C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science 342: 1508-1512.
16. Gerhardt GA, Rose GM, Hoffer BJ (1986) Release of monoamines from striatum of rat and mouse evoked by local application of potassium: evaluation of a new in vivo electrochemical technique. J Neurochem 46: 842-850. (Pubitemid 16114400)
17. Alsiö J, Nordenankar K, Arvidsson E, Birgner C, Mahmoudi S, et al. (2011) Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 12593-12603.
18. Dluzen De, McDermott Jl (2008) Sex Differences in Dopamine- and Vesicular Monoamine-Transporter Functions. Annals of the New York Academy of Sciences 1139: 140-150.
19. Borland LM, Michael AC (2007) An Introduction to Electrochemical Methods in Neuroscience. In: Michael AC, Borland LM, editors. Electrochemical Methods for Neuroscience. Boca Raton (FL).
20. Friedemann MN, Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13: 325-332.
21. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain research 290: 390-395. (Pubitemid 14217008)
22. Paxinos G (2004) The mouse brain in stereotaxic coordinates: Gulf Professional Publishing.
23. Reith ME, Xu C, Chen NH (1997) Pharmacology and regulation of the neuronal dopamine transporter. European journal of pharmacology 324: 1-10. (Pubitemid 27160902)
24. Michael AC, Ikeda M, Justice JB Jr (1987) Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation. Brain Research 421: 325-335. (Pubitemid 18021640)
25. Cosgrove KP, Mazure CM, Staley JK (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biological psychiatry 62: 847-855. (Pubitemid 47488220)
26. Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA (2000) Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. European journal of nuclear medicine 27: 867-869. (Pubitemid 30456771)
27. Laakso A, Vilkman H, Bergman J, Haaparanta M, Solin O, et al. (2002) Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry 52: 759-763.
28. Häfner H (2003) Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl 2: 17-54.
29. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, et al. (1997) Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 94: 4572-4575. (Pubitemid 27194283)
30. Bruun RD, Budman CL (1997) The course and prognosis of Tourette syndrome. Neurologic clinics 15: 291-298. (Pubitemid 27202915)
31. Shulman LM (2007) Gender differences in Parkinson's disease. Gender medicine 4: 8-18.